Gujarat

We are the university driven by our fundamental values and well defined vision. We are proud to offer dynamic career with personal growth; a strong tradition of mutual trust and integrity; an opportunity to create an impact on the working of the university. So, if you are interested in establishing a solid career, taking giant stride in personal growth, connecting with an institute with high standards like you have never thought possible, UTU is just the family to be a part of.

Post: Professors, Associate Professors, Assistant Professors

A Leading Pharma Group with Global Presence and approvals from EU-GMP, MHRA-UK. ANVISA Brazil. PICS Ukraine .WHO Geneva, INVIMA Colombia. Exposure of working with Regulatory Approved facilities will be desired For our (Solid Oralsflnjectables) manufacturing Facilities at Baddi (H.P.) require:

Cadila Pharmaceuticals Ltd. (CPL) is one of India's most reputed, research-based, techno-savvy pharmaceutical companies with a focus in the area of Formulations & APIs and having its corporate office at Bhat, Ahmedabad and State-Of-Art manufacturing facilities compliant with USFDA, MHRA, TGA, MCA, MCC & WHO norms at Dholka, Ankleshwar, Kadi and Jammu.

Post : Quality Control - Sr Officer / Executive / AM /DM

GPSSB, ahmedabad invites online applications for direct recruitment of compunder or pharmacists (class-3). Candidates can apply from 17-11-2016 to 30-11-2016 (till night 11.59 hour) and exam bees should be deposited in post ofiice till 02-12-2016. Candidate should upload recent photograph and signature in scan format.

Post: Compounder

We, Gufic Lifesciences Private Limited is coming with manufacturing facilities of PIC's, MHRA, USFDA requirement for formulation of Lyophilization injectables at Navsari (Gujarat) for which we are looking for competent candidates.

USV is aleading healthcare company with the following areas of focus: Generics, Active Pharmaceutical Ingredients (APIs) and Biosimilars. 68% of our business is contributed by India Operations and the rest by export of APIs and Generics. USV is a 48 year old healthcare company which began as a joint venture with USV&P Inc, a subsidiary of Revlon. Product range consists of Generics, Active Pharmaceutical Ingredients and Biotherapeutics that are manufactured in our modern cGMP compliant plants located in India.

{ DOWNLOAD AS PDF }

ABOUT AUHTOR
HardikRana*, BhargavVaghasiya, MansiDholakia
Department of Pharmaceutics,
Anand Pharmacy College, Anand, 388 001, Gujarat, India.
*hardikrana1439@gmail.com

ABSTRACT
The objective of present study was to enhance the solubility of poorly soluble drug Ibuprofen using spherical crystallization technique.The potential agglomerates were prepared by addition of different concentrationof polymer selected on the basis of Phase solubility study. Spherical agglomerates were prepared using diethyl ether as bridging liquid by neutralizing technique, spherical agglomeration technique, Quasi emulsion solvent diffusion technique. Spherical agglomerates were evaluated for morphology, production yield, drug content, particle size and dissolution behaviour compared with pure drug.The result of phase solubility studies revealed that there is enhancement of solubility by PEG 4000. Rod shaped crystals of pure drug converted to spherical was confirmed by optical microscopy. The dissolution of agglomerates of optimum batch exhibited 88.24% release compare to 47.18% of pure drug within 60 minute. This study demonstrated that spherical crystallization technique can be consider as a suitable alteration of granulation. Ibuprofen spherical agglomerates can be prepared with PEG 4000. It exhibited excellent physicochemical, solubility, dissolution rate in comparison with pure drug. Among other spherical crystallization technique, QESD proved to be excellent techniquefor enhancement of solubility and dissolution.

{ DOWNLOAD AS PDF }

ABOUT AUHTOR
Manish Patil*¹, Harsha D Jani¹, Suleman S Khoja², Narmin A Pirani³, Shamim S Khoja^3
1Department of Quality Assurance,
Shivam Pharmaceutical Studies and Research Centre, Anand
Gujarat, India.
²Resource person in pharmaceutical quality assurance and Audit Compliance, Vapi
³Registered Pharmacist, Gujarat, India
*manishpatil3194@gmail.com

ABSTRACT
This review article presents the pharmacology of combined Metformin hydrochloride and Teneligliptin hydrobromide hydrate is effective on type 2 Diabetes Mellitus. Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Teneligliptin, a third generation Dipeptidyl Peptidase-4 (DPP-4) inhibitor exhibits unique “J shaped” structure with “anchor-lock domain” mechanism which provides potent & long duration of action. The addition of teneligliptin once daily to Metformin was effective and generally well tolerated in Korean patients with type 2 diabetes. The mechanism of Metformin hydrochloride and teneligliptin hydrobromide hydrate is quite different. The main objective of this review article is to provide pharmacological and Analytical information of combination of Metformin hydrochloride and Teneligliptin hydrobromide hydrate to researcher in development of combined dosage form.

[adsense:336x280:8701650588]